Granulocyte-macrophage colony-stimulating factor - BioTransplant

Drug Profile

Granulocyte-macrophage colony-stimulating factor - BioTransplant

Alternative Names: GM-CSF - BioTransplant; Porcine GM-CSF; Porcine GM-CSF - BioTransplant

Latest Information Update: 12 Mar 2004

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator BioTransplant (CEASED)
  • Class
  • Mechanism of Action Granulocyte macrophage colony stimulating factor agonists; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Xenotransplant rejection

Most Recent Events

  • 12 Mar 2004 It appears that BioTransplant has ceased operations
  • 28 Nov 2003 BioTransplant expects to file with the Banruptcy Court in the coming weeks
  • 28 Feb 2003 BioTransplant and Eligix have filed voluntary Chapter 11 petitions
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top